CWM, LLC
- SEC CIK
- 0001535847
- Latest filing
- May 14, 2026
PTIX holding history
Protagenic Therapeutics, Inc. in every 13F filed by CWM, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PTIX overviewAll 13F holders of PTIXFull Q1 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 17
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1−100.0% | Sold out | Holders |
| Q4 2025 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2025 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2024 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2023 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2023 | 1 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2023 | 1 | $0 | 0.0% | +1 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −1−100.0% | Sold outConverted for a 1-for-4 split | Holders |
| Q4 2022 | 3 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2022 | 3 | $0 | 0.0% | +3 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −3−100.0% | Sold out | Holders |
| Q4 2021 | 3 | $0 | 0.0% | – | No prior filing | Holders |
| Q3 2021 | – | – | – | – | Not filed | Holders |
| Q2 2021 | 3 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2021 | 3 | $0 | 0.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.